From: Cohort profile: seek, test, treat and retain United States criminal justice cohort
Studya | Study design | Follow-up time points | Individual inclusion and exclusion criteria |
---|---|---|---|
BRIGHT | |||
 BRIGHT 1 | Randomized/observational study of on-site rapid HIV testing at probation/parole office vs. off-site referral at a community health center | Baseline only | Unknown HIV status; on probation or parole in Baltimore, MD or Providence/ Pawtucket, RI and residence in the Baltimore or Providence/Pawtucket area throughout the study period |
 BRIGHT 2 | RCT of case management (Project Bridge) vs. TAU | 3,6,12,15,18 months | HIV-infected; on probation or parole in Baltimore, MD and planned residence in greater Baltimore area throughout the study period |
CARE+ | |||
 RCT | RCT of CARE+ Corrections intervention | Monthly for 24 months | Aged 18+; HIV-infected; released from the correctional facility or half-way house ≤6 months ago and living in Washington, DC metropolitan community (not a restricted setting, e.g. half-way house) or currently detained in jail with anticipated release to community (not a restricted setting); reading at 8th grade level and English-speaking |
 HCV RIDOC | Cross-sectional study of HCV testing | Baseline only | Aged 18+; self-reported as HCV negative and documented HCV infection during Department of Corrections time with anticipated release between 3 and 12 weeks from enrollment; English-speaking |
 HCV PROB | Cross-sectional study of HCV testing | Baseline only | Aged 18+; self-reported as HCV negative or unknown; on probation or parole; English speaking |
IMPACT | RCT of IMPACT intervention vs. standard of care | 2, 6, 14, and 24Â weeks | Aged 18+; HIV-infected with HIV RNAÂ <Â 400 copies/mL receiving ART who were incarcerated in NC or TX and 3Â months prior to release and not convicted of sexual assault, death or serious injury; English-speaking |
LINK LA | RCT of intervention | 2, 6, 12Â months | Male or transgender individuals, aged 18+; HIV infected; incarcerated in a single facility for 5+ days; residing in Los Angeles County, CA upon release; English fluency |
NEW HOPE | Placebo-controlled RCT of. extended-release naltrexone | Monthly for 12Â months | Aged 18+, HIV-infected, meeting DSM-IV criteria for opioid dependence, within CT corrections system and not pending trial for a felony, within 30Â days of being released to greater New Haven, Hartford, Waterbury or Springfield areas or 30Â days after release; English- or Spanish-speaking, no liver failure or grade IV hepatitis, no active opioid withdrawal, no receipt of methadone or buprenorphine/naloxone for treatment of opioid dependency, no participation in pharmacotherapy trial in the previous 30Â days |
STT | Observational study of comprehensive Seek Test Treat strategies with medical record linkage 2Â years post-release | 2Â years | Aged18+; admitted to a detention facility, expected to be released to Milwaukee County, WI who were willing to be tested for HIV; verbal communication in English |
STT ILLINOIS | |||
 OPT OUT | Cross-sectional study of opt-out HIV testing | Baseline only | Aged 18+; detained in the IL corrections system |
 CM JAIL | Non-randomized study of case-management intervention vs. standard of care | 6, 12, 18 months | Aged 18+; HIV-infected; detained in IL corrections system (jail); expecting to reside in Chicago after release |
 CM PRISON | Non-randomized study of case-management intervention vs. standard of care | 6, 12, 18 months | Aged 18+; HIV-infected; recently released from IL corrections system (prison); enrollment was within 60 days of release |
START | 1. RCT of CARE-Rapid (computer-assisted program) vs. TAU and 2. quasi-experimental study of manualized intervention vs. TAU, with follow-up at 3Â months | 3Â months | Men aged 18+ with either unknown or believed negative HIV status within 90Â days of release from NY detention center entering a residential substance abuse treatment program |
STRIDE | |||
 STRIDE 1 | RCT of buprenorphine vs. placebo | Monthly for 12 months | Aged 18+; HIV-infected; meeting DSM-IV criteria for opioid dependence; resident of Washington, DC with eligibility for medical entitlements; English- or Spanish-speaking; no current opiate medications for chronic pain conditions or need to be placed on such medications; no current methadone doses over 30 mg/day, no AST and ALT >5× the ULN; no pregnancy or breast-feeding; no liver dysfunction; no suicidal ideation; no participation in pharmacotherapy trial in the previous 30 days |
 STRIDE 2 | Longitudinal cohort study comparing treatment using opioid substitution therapy to no treatment | 3, 6, 9, 12 months | Aged 18+; HIV-infected; meeting DSM-IV criteria for opioid dependence; resident of Washington, DC with eligibility for medical entitlements; English-speaking |
SUCCESS | Non-randomized pilot study of Strengths-Based case management and texting | 3, 12Â months | Aged 18+; HIV-infected; detained or sentenced in jail or detention center and likely to leave within 6Â weeks; no recent participation in randomized trial to improve retention in HIV care; English-speaking |
UHS II | |||
UHS IIC | Cross-sectional study of HIV testing | Baseline only | Aged 18+; crack cocaine or injection drug use in the past 30Â days |
UHS IIL | Longitudinal cohort study of case management (Project Bridge) vs. usual treatment | Quarterly for 24Â months | Aged 18+; HIV-infected; crack cocaine or injection drug use in the past 30Â days |